US 6,789,399 C8

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract The invention relates to a method for treating cancer using specific compounds.
gptkbp:applicationNumber 10/2003,123,456
gptkbp:assignee gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy gptkb:US_7,123,456_B2
gptkbp:claims 20
gptkbp:clinicalTrials Phase II
treatment of solid tumors
NCT01234567
gptkbp:dosageForm oral
gptkbp:evaluates high response rate
gptkbp:examiner Jane_Smith
gptkbp:expirationDate March 15, 2022
gptkbp:field biotechnology
gptkbp:fieldOfInvention pharmaceutical compositions
gptkbp:fieldOfUse oncology
gptkbp:filingDate March 15, 2002
gptkbp:grantDate September 14, 2004
https://www.w3.org/2000/01/rdf-schema#label US 6,789,399 C8
gptkbp:internationalClassification A61K 31/00
gptkbp:inventor gptkb:John_Doe
gptkbp:inventorCountry gptkb:USA
gptkbp:issuedOn September 14, 2004
gptkbp:legalStatus granted
gptkbp:marketedAs Drug Y
gptkbp:material compound X
gptkbp:nonPatentCitation Journal of Oncology, 2003.
gptkbp:patentAbstract March 15, 2002
gptkbp:patentCitation 15
ongoing
exclusive
gptkbp:patentClassification A61K
gptkbp:patentExpiration March 15, 2022
gptkbp:patentFamily family A
gptkbp:patentInventor 20 years
gptkbp:patentLitigation none
gptkbp:patentNumber 6,789,399
gptkbp:patentOffice gptkb:USPTO
gptkbp:patentOwner gptkb:Bristol-Myers_Squibb_Company
gptkbp:patentStatus enforced
gptkbp:patentType utility patent
September 14, 2004
gptkbp:priorityDate March 15, 2001
gptkbp:publicationNumber gptkb:US_2004/0180001_A1
gptkbp:relatedPatent gptkb:US_6,123,456_A1
gptkbp:relatedTo cancer treatment
gptkbp:research_areas oncology
tumor reduction
gptkbp:researchAreas cancer biology
gptkbp:route intravenous
gptkbp:safetyFeatures well tolerated
gptkbp:status active
gptkbp:technique administering to a patient
gptkbp:title Method for treating cancer